Clinical trials
Active, not recruiting Phase 2 Adenocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| AstraZeneca | 1 |
| Boston Scientific Corporation | 1 |
| Columbia University | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Genentech, Inc. | 1 |
| Harry H Yoon | 1 |
| Maia Biotechnology | 1 |
| Ruijin Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 15 |
| Stomach Neoplasms | 3 |
| Carcinoma | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Squamous Cell | 2 |
| Esophageal Neoplasms | 2 |
| Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Brain Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.